Inflammatory myofibroblastic tumor of the larynx: A case report by Izadi, F. et al.
 
 
 
 
79 
      
Iranian Journal of Otorhinolaryngology, Vol.28(1), Serial No.84, Jan 2016 
Case Report  
 
Inflammatory Myofibroblastic Tumor of the Larynx: 
A Case Report 
Farzad Izadi
1
,
*
Hadi Ghanbari
2
, Mohammad Reza Azizi
3
, Shahram Gasembaglou
1
,  
Mohammad Javad Manteghi
4
, Azadeh Ghanbari
5
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
Abstract  
 
Introduction: 
Inflammatory myofibroblastic pseudotumors are initially described in the lung and various 
extrapulmonary sites such as the orbits, palatine tonsils, ears, gingiva, pterygomaxillary space, 
and periodontal tissues. These tumors rarely involve the larynx and predilection to the glottis 
occurs in an indolent manner.  
 
Case Report:  
This case describes a laryngeal myofibroblastic tumor in a 46-year-old woman who presented 
with an aggressive tumor that extended to the floor of the mouth and the base of the tongue. 
Extended supraglottic laryngectomy was undertaken for the patient. The diagnosis was spindle 
cell proliferation with dense lymphoplasma cell infiltration compatible with inflammatory 
myofibroblastic tumor (Inflammatory pseudotumor or plasma cell granuloma). Definitive 
diagnosis was achieved with immunohistochemical (IHC) staining.  
 
Conclusion:   
We believe that further IHC studies are required to define the true nature of these tumors 
especially for those that behave in an aggressive pattern. 
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Introduction  
Inflammatory myofibroblastic tumors 
(IMFT) represent a heterogeneous group of 
unusual pseudo neoplastic lesions that 
appear to encompass a wide spectrum of 
histopathological features ranging from 
plasma cell rich to a high presence of 
myofibroblasts (1,2). Although IMFT was 
initially described in the lung (3), it has 
subsequently been reported in various 
extrapulmonary sites including the head and 
neck. IMFT is a benign fibroinflammatory 
mass of unknown etiology, and the true 
nature of IMFT is only now beginning to be 
elucidated (4-6). IMFT has many synonyms: 
plasma cell granuloma, inflammatory 
pseudotumor, xanthogranuloma, 
histiocytoma, and myofibrohistiocytic 
proliferation. IMFT was first described in 
1992 and presents many diagnostic 
challenges especially in the differentiation 
from a benign reactive process to a 
malignant one; however the diagnostic 
process could be further elucidated by 
observation of the behavior of IMFT and by 
further pathological findings.  
 
Case Report 
A 46-year-old woman presented with 
symptoms of potato voice and globus 
sensation for 4 years with no history of 
trauma or previous operation. She 
underwent a direct laryngoscopy, which 
revealed a thickness of the aryepiglottic 
fold and vallecula on the right side with a 
submucosal mass at the laryngeal surface 
of the epiglottis. The patient underwent a 
conservative laser resection of the 
involved area. Pathology showed fibrosis 
only, without any presence of atypias. One 
and half year later, symptoms recurred. 
Another laser procedure was undergone 
but the report remained the same. In the 
last 2 years, tumor growth occurred so 
rapidly that a CO2 laser transoral resection 
was preformed twice. 
Unfortunately, endoscopic photos of the 
preoperative intra laryngeal surgeries do 
not exist. Before the open surgery, 
pathology showed squamous and 
respiratory type mucosa with superficial 
edema and fibrosis of the deep stroma with 
no mucosal epithelium atypia. CT showed 
a large heterogeneous enhanced mass, 
30×24 mm in size, located on the right 
side of the base of the tongue with 
involvement of the genioglossus, 
hyoglossus, and mylohyoid muscles. There 
was a posterior-inferior extension of the 
mass to the vallecula and pre-epiglottic 
space; in addition to a thickened 
aryepiglottic fold in the presence of intact 
fat planes (Fig.1).  
Fig 1: right uptake at the base of tongue (Upper) 
involvement of the superior part of the 
layngx((lower). 
Upon admission, the patient had a stridor at 
rest due to the involvement of the base of the 
tongue and supraglottic region. The patient 
underwent extended supraglottic 
laryngectomy due to repeated recurrence and 
surgeries. The surgical area was primarily 
reconstructed because of the unilateral mass. 
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This mass presented as an irregular-shaped 
piece of rubbery, which was a firm and 
grayish brown tissue, measuring 3×2.5×2 
cm and was sent for evaluation. 
Immunohistochemical staining showed 
spindle cell positive reaction for SMA and 
ALK. No reaction for CD34, AE1/3 or 
desmin was observed; but BcL2 showed a 
positive reaction in inflammatory cells (Dr 
Nassizade, Iranian Blood Transfusion organi 
zation,IHC Lab. Ref#90-590)(Fig.2 a,b,c, d). 
 
 
 
 
Fig 2: Microscopic: sections show dense spindle cell 
proliferation with storiform growth pattern 
associated with patchy infiltration of lymphoplasma 
cells (a,b), and positive reaction of tumor cells with 
SMA(c) and Alk-1(d). 
The diagnosis was spindle cell proliferation 
with dense lympho- plasma cell infiltration 
compatible with inflammatory myofibro- 
blastic tumor (Inflammatory pseudotumor or 
plasma cell granuloma).  
 
Discussion  
IMFT, termed by Weing et al., indicates a 
proliferative myofibroblastic growth. IMFT 
has been reported throughout the body under 
a variety of names and the majority of the 
lesions follow a benign clinical course and 
rarely reoccur locally. IMFT should be 
considered when histological findings from 
an inflammatory mass are inconclusive. 
Development of this pseudotumor in the 
head and neck should always be kept in 
mind otherwise the diagnosis could be 
difficult. The etiology and pathogenesis of 
IMFT is still a mystery. Some investigators 
consider it to be an immunological host 
response to many different stimuli; but 
cytogenetic and molecular studies have 
pointed to the possibility that at least some 
subsets of IMFT are, in fact, true neoplasms. 
However, one subset of IMFT is mostly 
probably associated with infection.  
Histologically, IMFTs are composed of 
myofibroblastic spindle cells that are mixed 
with a prominent infiltrate of lymphocytes, 
plasma cells, and acute inflammatory cells. 
The three basic histological patterns were 
described by Coffin et al and are as follows: 
myxoid, vascular, and inflammatory areas 
resembling nodular fascitis; compact spindle 
cells with intermingled inflammatory cells 
resembling fibrous histiocytoma; and dense 
plate-like collagen resembling a desmoid or 
fibrous scar (7,8). The main differential 
diagnoses are epidermoid carcinomas with 
spindle-shaped cells, malignant mesenchy- 
matous tumors (fibrosarcomas, chondros- 
arcomas, histiocytomas, and others),  and 
lymphomas. True IMFTs must be distingui- 
shed from inflammatory pseudotumors 
developing in response to a healing process, 
injury, or infection. Treatment options 
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include laser assisted endoscopic excision, 
high dose steroids but rarely radiation and 
open excisions. Endoscopic excision with or 
without steroids is considered to be the first 
line of treatment as only few recurrences 
have been reported (9). In this case, the 
supraglottic inflammatory myofibroblastic 
tumor had an invasive behavior and 
progressive nature with extension to the base 
of the tongue and floor of the mouth (Fig.1). 
After several conservative CO2 laser 
surgeries, the patient had to undergo open 
surgery(extended supraglottic laryngectomy) 
due to the involvement deep into the 
supraglottic region and the presence of 
progressive symptoms. However, the patient 
was discharged with no morbidity, even 
though the resection involved the unilateral 
base of the tongue. Up to now, the patient 
has been symptom free.  
 
Conclusion 
IMFTs of the larynx are uncommon and 
carry a good prognosis but further IHC 
studies are required to define the true 
nature of these tumors and to categorize 
the aggressive subtypes of this tumor. 
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